Armed with new data, officials target drug-dealing doctors

Published On 2018-01-03 04:16 GMT   |   Update On 2018-01-03 04:16 GMT
Advertisement

PITTSBURGH: Federal prosecutors say a strategy that gives them better access to drug and health-care data is helping them stop doctors who irresponsibly prescribe addictive pain pills.


It's called the Justice Department's Opioid Fraud and Abuse Detection Unit. The unit provides authorities in 12 regions with information on which doctors are prescribing the most, how far patients will travel to see them and whether any have died within 60 days of receiving a prescription.


The unit's first indictment involved a Pittsburgh doctor accused of prescribing opioid painkillers to people who did not need them. Such pills are blamed for ushering the nation into its worst drug crisis in history.


Some experts say the focus may cause patients who legitimately need pills to be abandoned by doctors who fear prosecution.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News